<DOC>
	<DOCNO>NCT01783548</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Beclomethasone dipropionate ( BDP ) nasal aerosol subject Perennial Allergic Rhinitis ( PAR ) .</brief_summary>
	<brief_title>Study Investigational Nasal Aerosol Placebo Children ( Ages 4 11 ) With Perennial Allergic Rhinitis ( PAR )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<criteria>Male female subject 4 11 year age , inclusive , Screening Visit ( SV ) . A documented history PAR relevant perennial allergen minimum 12 month ( 6 month subject 4 5 year age ) immediately precede study Screening Visit ( SV ) . A demonstrated sensitivity least one allergen know induce PAR standard skin prick test . Other criterion apply . History physical finding nasal pathology , include nasal polyp clinically significant respiratory tract malformation , recent nasal biopsy , nasal trauma ( e.g. , nasal pierce ) surgery , atrophic rhinitis , rhinitis medicamentosa ( within last 60 day prior Screening Visit [ SV ] ) . History respiratory infection disorder ( include , limited bronchitis , pneumonia , chronic sinusitis influenza ) within 14 day precede Screening Visit ( SV ) , development respiratory infection RunIn Period . Active asthma require treatment inhale systemic corticosteroid and/or routine use betaagonists controller drug ( e.g. , theophylline , leukotriene antagonist ) . History intermittent use ( less equal 3 us per week ) inhale short acting betaagonists prior Screening Visit ( SV ) acceptable . Have follow condition judge investigator clinically significant and/or affect subject 's ability participate clinical trial . Other criterion apply .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>allergic rhinitis</keyword>
	<keyword>pediatric subject</keyword>
	<keyword>BDP nasal aerosol</keyword>
</DOC>